
Clopimet 75mg Tablet
Marketer
Sree Cvr Pharmaceuticals
Salt Composition
Clopidogrel (75mg)
Overview Clopimet 75mg Tablet
CardioGuard 75mg tablets are antiplatelet agents, preventing the formation of dangerous blood clots within your circulatory system. This reduces your risk of stroke and heart attack, making it a common preventative medication. CardioGuard 75mg is prescribed for individuals at elevated risk of cardiovascular events, including those with peripheral arterial disease (reduced blood flow due to narrowed arteries), recent heart attack or stroke, arrhythmias, and post-stenting. It's also used alongside other medications to treat heart attacks and unstable angina. This medication can be taken with or without food, but consistently at the same time daily. Continued use is crucial; discontinuation increases stroke and heart attack risk. The most frequent side effect is increased bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual flow. Minor injuries may bleed more profusely and for longer. Though usually self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in individuals with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage). Inform your physician of any bleeding disorders, recent significant trauma, or upcoming surgery or dental procedures before starting treatment; temporary discontinuation may be necessary.
Primary Ingredients of Clopimet 75mg Tablet
No text provided to rephrase.
Uses of Clopimet 75mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Clopimet 75mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clopimet 75mg Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Clopimet 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clopimet 75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clopimet 75mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Clopimet 75mg Tablet works:
Seven-five milligram Clopimet tablets are prescribed to inhibit platelet aggregation. Their mechanism of action prevents platelet clumping, thus reducing the risk of dangerous thrombus formation and consequently, the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Clopimet 75mg Tablet concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Clopimet 75mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingSAFE IF PRESCRIBED
The use of Clopimet 75mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Clopimet 75mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely take Clopimet 75mg tablets without requiring a dosage modification.
LiverSAFE IF PRESCRIBED
Clopimet 75mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Clopimet 75mg Tablet :
Should you forget a Clopimet 75mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clopimet 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alpha esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Active Class | ADP receptor antagonists (P2Y12 inhibitors) |
